Taysha Gene Therapies, Inc. (TSHA)

NASDAQ: TSHA · IEX Real-Time Price · USD

2.140

-0.120 (-5.31%)

At close: Jul 19, 2024, 4:00 PM

2.250

+0.110 (5.14%)

Pre-market: Jul 22, 2024, 9:07 AM EDT

Taysha Gene Therapies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	126.58	146.54	90.52	151.74	251.25
Cash & Cash Equivalents	126.58	146.54	90.52	151.74	251.25
Cash Growth	91.61%	61.89%	-40.35%	-39.61%	-
Other Current Assets	4.02	3.33	5.9	7.86	6.63
Total Current Assets	130.6	149.87	96.42	159.6	257.88
Property, Plant & Equipment	19.95	20.41	25.91	50.61	0.29
Other Long-Term Assets	2.46	2.46	3.95	3.74	0.72
Total Long-Term Assets	22.4	22.86	29.86	54.35	1
Total Assets	153	172.73	126.28	213.96	258.88
Accounts Payable	10.38	6.37	10.95	21.76	1.99
Deferred Revenue	14.7	18.11	33.56	0	0
Other Current Liabilities	13.56	12.28	18.29	29.98	5.14
Total Current Liabilities	38.64	36.76	62.79	51.75	7.13
Long-Term Debt	59.01	59.46	58.41	37.19	0
Other Long-Term Liabilities	1.5	1.58	4.13	29.64	0.45
Total Long-Term Liabilities	60.51	61.04	62.54	66.83	0.45
Total Liabilities	99.15	97.79	125.33	118.57	7.58
Total Debt	59.01	59.46	58.41	37.19	0
Debt Growth	1.59%	1.80%	57.04%	-	-
Retained Earnings	-537.07	-513.01	-401.44	-235.65	-61.13
Comprehensive Income	-0.25	0	0	0	0
Shareholders' Equity	53.85	74.94	0.95	95.38	251.3
Net Cash / Debt	67.57	87.08	32.11	114.55	251.25
Net Cash / Debt Growth	747.47%	171.19%	-71.97%	-54.41%	-
Net Cash Per Share	0.29	0.75	0.73	3.04	14.22
Working Capital	91.96	113.11	33.63	107.86	250.75
Book Value Per Share	0.23	0.65	0.02	2.53	14.22

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).